ArticleFrontiers in medicine2026
Interpretable machine learning to predict NOAF in ICU patients with CKD: validation in US and Chinese cohorts.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Critically ill patients with chronic kidney disease (CKD) are at high risk for New-Onset Atrial Fibrillation (NOAF), which significantly increases their risk of adverse events. Early detection of NOAF is crucial for prompt intervention and better outcomes. This study aims to develop and validate predictive models for the early identification and stratification of NOAF risk in this vulnerable population. Methods: We developed and validated a predictive model using a cohort of 6,476 critically ill patients with CKD from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database. After performing feature selection via least absolute shrinkage and selection operator (Lasso) logistic regression, we trained six machine learning (ML) models. These algorithms included: Random Forest, Gradient Boosting, eXtreme Gradient Boosting (XGBoost), Logistic Regression (LR), Multi-layer Perceptron (MLP), and Light Gradient Boosting Machine (LightGBM). The best-performing model was interpreted using SHAP to provide clinical insights. Its robustness and generalizability were confirmed through rigorous external validation on two distinct international cohorts: the US-based eICU-CRD (eICU Collaborative Research Database) ( Results: Ultimately, 12 predictive features were ultimately selected: age, SOFA score, minimum heart rate, congestive heart failure, average heart rate, minimum systolic blood pressure (SBP), mechanical ventilation use, minimum oxygen saturation (SpO Conclusion: We developed an interpretable machine learning model to predict NOAF in critically ill CKD patients, demonstrating strong generalizability through external validation on both a large US cohort (eICU-CRD) and a single-center Chinese cohort (Weifang People's Hospital). SHAP analysis enhanced model interpretability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.